Patent · US Active

Anti-FcRH5 antibodies and immunoconjugates and methods of use

US8466260B2 · kind B2 · utility

15Cited by
16References
49Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 31, 2010
Grant dateJun 18, 2013
Priority date
Expiry dateDec 20, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.